non-Hodgkin's lymphoma News
Most Popular non-Hodgkin's lymphoma Story
Cell Therapeutics shares soar on Phase III data
A late-stage study of Cell Therapeutics' pixantrone demonstrated its ability to significantly increase the remission rates of patients with non-Hodgkin's lymphoma. And investors moved swiftly to push... Read more...
Latest Headlines
- June 2, 2009
- October 7, 2008
- September 18, 2007
- August 16, 2007
- January 7, 2007
- December 18, 2006
- October 8, 2006
- September 26, 2006
- August 3, 2006
- January 11, 2006
- October 30, 2005
- July 25, 2005
- May 25, 2005
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
